Emergent BioSolutions Inc. (0IGA.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 661.26M |
| Enterprise Value | 1.05B |
| P/E Ratio | -1.17 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 0.47 |
| Price/Book Ratio | 0.96 |
| Enterprise/Revenue | 0.98 |
| Enterprise/EBITDA | -5.42 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.4 |
| Operating Margin | -0.26 |
| Return On Assets | -0.26 |
| Return On Equity | -0.61 |
| Revenue | 742.9M |
| Revenue/Share | 12.65 |
| Gross Profit | 361.2M |
| EBITDA | 217.9M |
| Net Income | 52.6M |
| Diluted EPS | 0.93 |
| Total Cash | 176.9M |
| Total Cash/Share | 3.42 |
| Total Debt | 513.7M |
| Total Debt/Equity | 1.62 |
| Current Ratio | 4.58 |
| Book Value Per Share | 6.11 |
| 52-Week Change | -46.27 |
| 52-Week High | 13.91 |
| 52-Week Low | 4.37 |
| Moving Average 50 Days | 6.53 |
| Moving Average 200 Days | 7.82 |
| Average Volume | 3,407 |
| Shares Outstanding | 51.42M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |